🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma Follicular › Georgia

Qorannoo klinikaalii Lymphoma Follicular Georgia keessatti

Qorannoo 15 Lymphoma Follicular f Georgia keessatti hirmaatuu jiru.

Magaalota Georgia keessatti

Takkalaa qorannoo (Ingiliffa)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Augusta University, Augusta
  • Southeastern Regional Medical Center, Newnan
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  • Augusta University Medical Center, Augusta
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07215910

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  • Emory University Hospital, Atlanta
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  • Research Site, Atlanta
  • Research Site, Macon
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06549595

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

  • Piedmont Healthcare, Atlanta
  • Winship Cancer Institute, Atlanta
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06784752

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

  • Emory University Hospital/Winship Cancer Institute, Atlanta
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Emory University, Atlanta
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Augusta University Medical Center, Augusta
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT03501576

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • Winship Cancer Institute of Emory University, Atlanta
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05131022

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital, Marietta
  • Southeastern Regional Medical Center, Newnan
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06911502

SynKIR-310 for Relapsed/Refractory B-NHL

  • Winship Cancer Institute of Emory University, Atlanta
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Elb-2026 · NCT06544265

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

  • Emory University Hospital/Winship Cancer Institute, Atlanta
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Gur-2026 · NCT04883437

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Atlanta
  • Massive Bio SYNERGY-AI site, Savannah
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.